The ED conducted searches at multiple locations in Mumbai as part of investigations against a company that duped investors after providing false assurances to set up data and digital learning centres ...
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for ...
These days, much online prose feels generic—flattened voice, repeated language, and similar punctuation. AI may now be infiltrating science journals These days, so much prose online is generic. There ...
The company highlighted active regulatory engagement with both the FDA and Japan’s PMDA, setting the stage for possible approval submissions in multiple geographies. Clinical trial data across both ...
Welcome to BioNTech's Third Quarter 2025 Earnings Call. I will now hand the call over to Doug Maffei, Vice President, Strategy and Investor Relations. Please go ahead. Thank you, operator. Good ...
Hosted on MSN
Stocks cautious as Nvidia earnings test looms
SINGAPORE (Reuters) -Asia's stock markets dipped on Monday and a deepening dispute between China and Japan hit shares in Tokyo, while investors looked ahead to a week of catch-up data and corporate ...
Lantern Pharma Inc. (LTRN) reported its third-quarter 2025 earnings, showing a net loss of $4.2 million, or $0.39 per share, an improvement from the $4.5 million loss, or $0.42 per share, in the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback